Dentsply Sirona Analyst Price Targets

Wall Street analyst price targets and consensus rating for Dentsply Sirona (XRAY).

Price Target Range — 13 Quarters

Analyst Consensus — 18 Analysts

4Buy

12Hold

2Sell

Consensus RatingNeutral# Analysts18Avg. Consensus PT$16Upside to Avg. PT+82.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 9, 2026	Piper Sandler	Jason Bednar	PT Cut	Neutral	$14→$12
Sep 17, 2026	BMO Capital	Vik Chopra	PT Cut	Market Perform	$13→$10
Aug 24, 2026	Barclays	Glen Santangelo	PT Raise	Underweight	$9→$11
Jul 29, 2026	Piper Sandler	Jason Bednar	PT Raise	Neutral	$13→$14
Jul 9, 2026	BMO Capital	—	Initiate	Market Perform	$12
Jun 4, 2026	Barclays	Glen Santangelo	PT Cut	Underweight	$12→$9
May 7, 2026	UBS	Kevin Caliendo	PT Cut	Buy	$18→$17
May 6, 2026	Mizuho	Steven Valiquette	PT Cut	Neutral	$16→$14
Apr 15, 2026	Citigroup	Daniel Grosslight	Initiate	Sell	$10
Mar 2, 2026	Mizuho	Steven Valiquette	PT Raise	Neutral	$14→$16
Mar 2, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$14→$17
Feb 27, 2026	Wells Fargo	Vik Chopra	PT Raise	Equal-Weight	$12→$13
Feb 27, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	In-Line	$12→$15
Feb 27, 2026	Baird	Jeffrey Johnson	PT Raise	Neutral	$12→$14
Feb 19, 2026	B of A Securities	Michael Cherny	Upgrade	Neutral→Buy	$13→$17
Feb 3, 2026	UBS	Kevin Caliendo	PT Cut	Buy	$17→$16
Jan 20, 2026	Mizuho	Steven Valiquette	PT Raise	Neutral	$13→$14
Jan 5, 2026	Barrington Research	Michael Petusky	Maintained	Outperform	$14
Dec 16, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$14
Dec 16, 2025	Baird	Jeffrey Johnson	PT Cut	Neutral	$14→$12

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12

Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.

Benzinga Newsdesk

PRO
BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10

BMO Capital analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $13 to $10.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

Barclays analyst Glen Santangelo maintains Dentsply Sirona (NASDAQ:XRAY) with a Underweight and raises the price target from $9 to $11.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises the price target from $13 to $14.

Benzinga Newsdesk

PRO
BMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12

BMO Capital initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Market Perform rating and announces Price Target of $12.

Benzinga Newsdesk

Wall Street's Most Accurate Analysts Give Their Take On 3 Healthcare Stocks Delivering High-Dividend Yields

In turbulent markets, investors turn to dividend-yielding stocks. Here are analyst ratings for high-yielding energy stocks.

Avi Kapoor

Dentsply Sirona Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Dentsply Sirona Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12

PRO
BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10

PRO
Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

PRO
BMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12

Wall Street's Most Accurate Analysts Give Their Take On 3 Healthcare Stocks Delivering High-Dividend Yields

People Also Watch

People Also Watch

Dentsply Sirona Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Dentsply Sirona Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROPiper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12

PROBMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10

PROBarclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

PROPiper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

PROBMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12

Wall Street's Most Accurate Analysts Give Their Take On 3 Healthcare Stocks Delivering High-Dividend Yields

People Also Watch

People Also Watch

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12

PRO
BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10

PRO
Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

PRO
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

PRO
BMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12